Financials
- Market Capitalization 138.85 M
- Employee 61
- Founded 1996
- CEO N/A
- Website www.acumenpharm.com
- Headquarter Delaware, United States
- FIGI BBG0058YJ317
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.05
市销率
638.93
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3674 | MOLN Molecular Partners AG - American Depositary Shares | 3.79 USD | -1.56% | -7.79% | -8.67% | +1.88% | 153.02 M USD | ||
| 3677 | NBP NovaBridge Biosciences - American Depositary Shares | 1.32 USD | 0.00% | -5.71% | -16.98% | -70.73% | 152.30 M USD | ||
| 3702 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.55 USD | -6.78% | -8.33% | -15.38% | +33.33% | 133.90 M USD | ||
| 3710 | RNA Atrium Therapeutics, Inc. - Common Stock | 8.08 USD | -1.58% | +3.59% | -22.08% | -88.51% | 138.21 M USD |